Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

Diabetes and Metabolic Hormones

28th Aug 2025

Examining empagliflozin’s safety profile across four clinical trials: a plain language summary

21st Jan 2025

Understanding the different stages of type 1 diabetes and their management: a plain language summary

17th Jan 2025

Dapagliflozin or saxagliptin in pediatric type 2 diabetes: a plain language summary

15th Sep 2022

Osilodrostat for the treatment of Cushing’s disease: a plain language summary of the LINC 4 study

20th May 2022

Plain language summary of the MPOWERED trial comparing the effectiveness, safety, and patient experiences’ of monthly injections and oral medication used to treat acromegaly

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy